
Sign up to save your podcasts
Or


Glaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting.
Learn more about your ad choices. Visit megaphone.fm/adchoices
By Eyewire NewsGlaukos commercially launches its topical drug therapy for keratoconus; BVI’s next-generation phaco-vitrectomy surgical system receives CE Mark; and the ASCRS Executive Director recaps the 2nd annual Sightline meeting.
Learn more about your ad choices. Visit megaphone.fm/adchoices